JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olianas, M. C.
Right arrow Articles by Onali, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olianas, M. C.
Right arrow Articles by Onali, P.

Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart

MC Olianas and P Onali

Department of Neurosciences, University of Cagliari, Italy.

The pharmacological profile of the muscarinic stimulation of adenylate cyclase activity in rat olfactory bulb was investigated by using a number of antagonists with different selectivity for the muscarinic receptor subtypes. Schild analysis showed that this response was counteracted with the following rank order of potency: R(- )quinuclidinyl benzilate greater than atropine greater than RS(+/-)-3- quinuclidinyl xanthene-9-carboxylate hemioxalate greater than S(+)quinuclidinyl benzylate greater than 4-diphenylacetoxy-N- methylpiperidine methbromide greater than secoverine greater than methoctramine greater than dicyclomine greater than hexahydrosiladifenidol greater than p-fluorohexahydro-sila-difenidol greater than AF-DX 116 greater than pirenzepine. In the heart and corpus striatum, the antagonist rank orders of potency in counteracting the muscarinic inhibition of adenylate cyclase activity were consistent with the involvement of homogeneous populations of M2 and M3 receptors, respectively. Conversely, in the olfactory bulb, the pirenzepine inhibition curve of acetylcholine-stimulated enzyme activity was biphasic, with a major component of the response being inhibited with low affinity. These results indicate that more than one receptor subtype may participate in the stimulation of adenylate cyclase in rat olfactory bulb. The predominant receptor involved appears to be different from the M1, M2 and M3 subtypes and pharmacologically equivalent to the m4 gene product.

Volume 259, Issue 2, pp. 680-686, 11/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
N. W. Delapp, J. H. McKinzie, B. D. Sawyer, A. Vandergriff, J. Falcone, D. McClure, and C. C. Felder
Determination of [35S]Guanosine-5'-O-(3-thio)Triphosphate Binding Mediated by Cholinergic Muscarinic Receptors in Membranes from Chinese Hamster Ovary Cells and Rat Striatum Using an Anti-G Protein Scintillation Proximity Assay
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 946 - 955.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.